Display options
Share it on

Chemioterapia. 1988 Aug;7(4):274-7.

Worldwide assessment of the activity of cefotetan against clinical isolates.

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy

P J Turner, J R Edwards

Affiliations

  1. Antibiotic Development, ICI Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, England.

PMID: 3180309

Abstract

Data on the antibacterial activity of cefotetan collected since 1985 have been compiled into a computer database and an analysis of results on more than 100,000 clinical isolates presented. The studies were conducted in 285 hospitals located throughout Europe, South Africa, Australia and the USA. The results demonstrate the effectiveness of cefotetan as a broad spectrum agent with significant activity against clinically important aerobes and anaerobes. This is exemplified by the susceptibility to cefotetan of 92% of 14,315 strains of Staphylococcus aureus, 99% of 24,103 strains of Escherichia coli and 93% of 1,841 strains of Bacteroides fragilis.

Substances

MeSH terms

Publication Types